Cwm LLC Has $1.78 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Cwm LLC lifted its position in Colgate-Palmolive (NYSE:CL) by 10.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 22,289 shares of the company’s stock after purchasing an additional 2,126 shares during the quarter. Cwm LLC’s holdings in Colgate-Palmolive were worth $1,777,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. OFI Invest Asset Management bought a new stake in Colgate-Palmolive during the 3rd quarter worth about $25,000. Avion Wealth boosted its stake in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock valued at $32,000 after purchasing an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $34,000. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the last quarter. Finally, West Branch Capital LLC boosted its stake in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a filing with the SEC, which is available through this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock worth $19,505,099. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on CL shares. UBS Group raised their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Finally, JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.50.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $89.27 on Friday. The company’s fifty day simple moving average is $87.51 and its 200-day simple moving average is $81.30. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The firm has a market cap of $73.38 billion, a PE ratio of 32.11, a P/E/G ratio of 3.33 and a beta of 0.42. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.37.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.77 earnings per share. Equities research analysts expect that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.24%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is presently 71.94%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.